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We have investigated whether an oxygen/ozone (95%O2/5%O3) mixture would have potential against the formation of
experimental postsurgical peritoneal adhesions. In two groups of rats, one control intraperitoneally injected with 3mL/rat of
O2 and one intraperitoneally injected with oxygen/ozone mixture (3mL/rat equivalent to 300µg/kg ozone), we induced a midline
laparotomy and an enterotomy at the level of the ileum to encourage the formation of peritoneal adhesions. Samples were taken
from the parietal peritoneal tissue to assess the formation of adhesions 0 and 10 days after the surgical procedure and to assess the
levels of ubiquitin and 20S proteasome. We found decreased formation of postsurgical peritoneal adhesions after treatment of the
rats with 300µg/kg ozone associated with a decreased levels of ubiquitin and 20S proteasome subunit within the adhered tissue.
Oxygen/ozone mixture is potentially useful for approaching the post-surgical peritoneal adhesions, and the UPS system is involved
in this.
1.Introduction
Postoperative adhesions by occurring in approximately 90%
of patients undergoing abdominal surgery determine post-
operative morbidity and mortality [1, 2]. They are connec-
tive bridges between adjacent portions of the peritoneum
[1] and develop following an extensive inﬂammatory process
within the tissue that involves mediators of inﬂammation or
not.
Adhesions recognize their genesis in mesothelial cells,
stimulated by the trauma surgery, which promote the
conversion of ﬁbrinogen into ﬁbrin, releasing thromboplas-
tin. Fibroblasts lay collagen ﬁbrils whereas there is ﬁbrin,
and so becoming adhesions [3]. Due to the putative molec-
ular mechanisms underlying the postsurgical peritoneal ad-
hesions, various strategies have been proposed to solve the
problem. These passed from the use of laparoscopic sur-
gery, pharmacological prevention with drugs acting on ﬁ-
brinolysis, interferons, and medical anaesthetic gases [4–
10]. In addition an important component of the adhesion
formationistheinﬂammatoryresponseoccurringwithinthe
peritoneum [4, 11, 12].
However, a nonspeciﬁc approach using an oxygen/ozone
gas mixture might lead to clinical beneﬁt in patients with
postsurgical peritoneal adhesions. Such an approach seeks to
attenuate the inﬂammatory response [13] in the unfolding
process of adhesions. In this context, our study evaluated
whether the application of a medical gaseous mixture of
oxygen/ozone during the surgery can be suggestive of a
reduction of the inﬂammatory events thatin cascadelead the
postsurgical peritoneal adhesions formation.
2. Methods
2.1. Surgical Procedure. All experimental procedures and
protocols used in this study were approved by the Animal
Care Ethical Committee of the 2nd University of Naples.2 Mediators of Inﬂammation
T h es u r g e r yw a sp e r f o r m e da sd e s c r i b e db yD iF i l i p p o
et al. [4]. Male Sprague-Dawley rats (n = 15) were
marked with a pencil as 1 to 15, anesthetized with urethane
(1.2g/kg ip), subjected to midline laparotomy. A sample of
parietal peritoneal tissue was taken, and an enterotomy was
performed at the level of the ileum. The surgical incision
was sutured with absorbable surgical wire 4/0 in order to
induce an inﬂammatory peritoneal insult. All of the surgical
procedure was then ended by a nonabsorbable suture, and
the rats were placed in the recovering room for awakening.
Ten days after the surgery (time T1) the rats were subjected
to another laparotomy having particular attention to keep
always the same rat numbering, had a new tissue sample
taken, and were assayed for the development of peritoneal
adhesions by means of qualitative and quantitative evalua-
tion. A score from 1 to 6 was established, and it was given
as follows: 1 to the presence of poor and lapse adhesions
in a limited peritoneal zone, 2 to the presence of poor
adhesions in an extended zone, 3 to the presence of several
lapse adhesions into the peritoneum, 4 to the presence of
localized dense adhesions, 5 to the presence of extended
dense adhesions with access to peritoneal cavity, and 6 to the
presence of extended dense adhesions and impossible access
to peritoneal cavity. The surgery and the scoring were always
done by the same person. Biopsies of peritoneal tissue were
snap frozen and used to determine levels and activity of the
UPS system.
2.1.1. Experimental Groups. The study was conducted on
male Sprague-Dawley rats (4–6 months old and weighing
250g)dividedintothefollowingexperimentalgroups:group
A( n = 15) induced with the surgical procedure + oxygen
(100% O2, 3mL/rat, injected in the abdominal cavity) and
group B (n = 15) induced with surgical procedure +
oxygen/ozone mixture (95%O2/5%O3,3 m L / r a te q u i v a l e n t
to 300µg/kg ozone injected in the abdominal cavity). Both of
the groups were ﬁrst treated with half volume 1 hour before
surgery; a second injection with the other half volume was
given 1 hour after the surgical procedure (total volume and
dosesasspeciﬁed).Therewerenosigniﬁcantsideeﬀectsafter
injections in both A and B groups.
2.1.2. Biochemical Parameters Assessed. The frozen tissue
samples were homogenized in 50mM Tris-HCl (pH 7.2)
containingleptin1µM,pepstatinA1µM,andphenylmethyl
sulfonyl ﬂuoride 200µM and centrifuged for 10min at
10,000×ga t4 ◦C.
200µL of homogenate was used to determine total
protein according to the Bradford’s method. The levels of
ubiquitin were quantiﬁed by commercial ELISA kit (Wuhan
EIAab Science Co., Wuhan, China) For the quantitative mea-
surement of the 20S proteasome, a speciﬁc SDS activation kit
(Boston Biochem, USA) was used following the instructions
of the manufacturer.
2.1.3. Statistics. Data are presented as mean ± S.E. Con-
tinuous variables were compared among the groups of rats
with one-way analysis of variance (ANOVA) for normally
distributed data and the Kruskal-Wallis test for nonnormally
distributed data. When diﬀerences were found among the
groups, the Bonferroni correction was used to make pairwise
comparisons. A P<0.05 was considered statistically
signiﬁcant. All calculations were performed using the SPSS2
software.
3. Results
Starting from day 10 after surgery, the rats treated with
the 3mL/rat 100% oxygen showed a high score for the de-
velopment of peritoneal adhesions (data not shown). After
10 days from surgery, 7 of the 15 rats treated with oxygen
3mL had the highest score assigned for the presence of
peritoneal adhesions. They showed presence of dense adhe-
sion and impossible access to peritoneal cavity with a score
of 6 assigned to them (Table 1) .T h r e er a t sw e r ea s s i g n e d
to a score of 5 with a presence of adhesion disseminated
within the peritoneum but still keeping the peritoneal access
(Table 1). The other rats showed overall lapse adhesions in
limited peritoneal zones and gained a score from 1 to 4
(Table 1).
In parallel with the development of peritoneal adhesions,
there was an increase in the levels of ubiquitin and the
20S proteasome within the adhered tissue. For both of the
markers, this increase was signiﬁcant (P<0.01 versus time
T0) 10 days after surgery (time T1) (Figures 1(a) and 1(b)).
T r e a t m e n to fr a t sw i t h3 0 0µg/kg oxygen/ozone mixture
prior to the induction of the surgical peritoneal insult
resulted in reduced score for formation of postsurgical per-
itoneal adhesions and reduced levels of ubiquitin and 20S
proteasome within the adhered tissue. The evaluation of
the peritoneal adhesions score, as shown in the Table 1,
indicates a substantial decrease of adhesions in the group of
rats treated with 300µg/kg oxygen/ozone mixture. This was
accompanied by a signiﬁcant reduction of the levels of both
ubiquitin and proteasome 20S (P<0.01 versus time T0) in
the peritoneal tissue 10 days after surgery (Figures 1(a) and
1(b)).
4. Discussion
Untilfewyearsagotopreventtheformationofadhesions,the
focuswasmainlyposedontheprocedurestobeimplemented
during the surgery. It is worth mentioning in this regard, as
there is considerable consensus on the laparoscopic surgery
as a procedure associated with less development of adhesions
compared to open surgery in the international arena [4,
5]. However, in recent years, numerous studies have been
aimed at a likely pharmacological prevention of postsurgical
adhesion formation as, for example, some authors proposed
the use of statins as they are considered able to increase
the peritoneal ﬁbrinolysis [8]. Other authors have suggested
that interferon-gamma is a possible therapeutic target to
prevent the formation of adhesions, due to its crucial role
in the diﬀerential regulation of PAI-1 and t-PA, which are in-
volved in this process [9]. However, other ones suggest theMediators of Inﬂammation 3
Table 1: Score assigned to rats 10 days after the induction of
the procedure for the development of peritoneal postsurgical ad-
hesions: 1, presence of few loose adhesions in a limited area of the
peritoneum. 6, presence of dense adhesions and failure in access to
the peritoneal cavity. The rats (n = 15 for each group) were treated
withoxygen(vehiclecontrol,3mL)andwithoxygen/ozonemixture
(3mL,equivalentto300µg/kg).Thesymbol+indicatestheanimals
showing adhesion.
Adhesions score Oxygen (3mL) Oxygen/ozone
(3mL; 300µg/kg)
1+ + +
2 ++ +++
3+ + +
4+ + +
5 +++ ++
6 +++++++ ++++
use of antitack agents such as carboxymethylcellulose and
hyaluronic acid resorbable membranes. Finally, it is also
alleged the possible use of propofol [10].
Here, we show that a mixture of oxygen/ozone applied to
rats prior to the induction of peritoneal injury exerts a pro-
tective action against the formation of postsurgical per-
itoneal adhesions.
Experimental and clinical evidences have proved advan-
tageous eﬀects of oxygen/ozone therapy in several patholo-
gies characterized by a cellular oxidative and inﬂammatory
burden, including renal injury, cardiopathy, atherosclerosis
and septic shock [14–19]. Recent data imply that ozone is
located in atherosclerotic arteries, and it has been proposed
that it may be important in additional human inﬂammatory
diseases [20]. Not last, oxygen/ozone administration has
been shown beneﬁcial in the prevention/reduction of the
myocardial tissue damage which follows an ischemic event
[21]. It protects the heart from acute myocardial infarction
through a series of local events that include, among the oth-
ers,increaseofeNOSactivityandendothelialprogenitorcells
recruitment[22].Therapeuticeﬃcacyagainstwoundhealing
and limb salvage in patients with critical limb ischemia are
also due to oxygen/ozone [23].
In a previous research, Di Filippo et al. [4] found that
postsurgicalperitonealadhesionsoccurinratsstrictlyrelated
to the time from the surgery and have severity depending on
the inﬂammatory response occurring within the peritoneal
specimens, which deteriors the peritoneal matrix. During
this phase, leukocytes, cytokines, chemokines, and cell
adhesion molecules alters the initial tissutal equilibrium pre-
disposing it to the formation of adhesions [4]. In the present
study, we show an involvement of the ubiquitin-proteasome
system (UPS) in the tissutal alterations that follows a surgical
intervention and development of peritoneal adhesions. This
latter relates to the severity of the adhesion; animals that
show high levels of UPS activity also have severe adhesions,
whilst animals that show low levels of UPS have moderate
adhesions.
UPS, generally known as the major pathway for nonlyso-
somal intracellular protein degradation in eukaryotic cells,
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Figure 1: Levels of proteasome 20S (a) and ubiquitin (b) in the
peritoneal tissues from rats during peritoneal adhesions develop-
ment after time 0 and 10 days in the group treated with oxygen
(vehicle control) and oxygen/ozone mixture (3mL, equivalent to
300µg/kg). The diﬀerences from time 0 are considered with ∗P<
0.01, and the diﬀerences from the group treated with oxygen are
shown as ◦P<0.05 and ◦◦P<0.01.
was discovered in the eighties by the pioneering work of
Goldberg, Hershko, and their collaborators, using reticulo-
cytelysates[24–26].TheUPSusuallydegradeproteinsintwo
steps. First, the substrate is covalently modiﬁed by addition
of a polyubiquitin chain, through an enzymatic cascade that
involves three classes of factors: E1, the ubiquitin- (Ub-)
activating enzyme [27], E2, a member of the family of Ub
carriers [28], and E3, a member of the very large family
(several hundred members) of the so-called Ub ligases [29],
which speciﬁcally recognizes and recruits the substrate of the
ubiquitylation reaction. Second, the ubiquitylated protein is
usually addressed to and degraded by the 26S proteasome, a4 Mediators of Inﬂammation
giant multisubunit and multicatalytic protease [30]. Due to
its multiple roles, the proteasome is essential in eukaryotes,
and its dysfunction has deleterious eﬀects for the cell or
the organism as a whole. In humans, UPS deregulation has
been implicated in a number of pathologies such as cancer,
autoimmune diseases, neurodegenerative diseases, or viral
infections. As a consequence, the proteasome is seen as a
potential therapeutic target in many pathologies [31], in-
cluding inﬂammation [32] and now tissue degeneration.
The present study demonstrates that the activity of the
UPS system, measured on adhesions biopsies, is modulated
by the treatment with the oxygen/ozone mixture. Following
oxygen/ozone treatment, the expression and the activity of
this system is diminished. An intriguing and somewhat
imaginative scenario would suggest that oxygen/ozone may
be able to inhibit the UPS activity in adhered tissue, possibly
leading to reduced local inﬂammatory boost and adhesions
formation.
In conclusion, the absolute novelty of this study is that
an oxygen/ozone mixture reduces the peritoneal adhesions
associated with a reduction of the ubiquitin-proteasome
system activity within the adhered tissue.
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